Not for publication in the U.S.
- The fully automated CN-3000 and CN-6000 Systems deliver advanced coagulation testing capabilities for laboratories of varying sizes.
- A broad menu of both routine and specialty coagulation assays from Siemens Healthineers can be performed on the CN-3000 and CN-6000 Systems.
- Designed for seamless integration with Atellica Data Manager (ADM), Atellica Process Manager (APM) and automation platforms, the systems enable hands-free workflows and centralized oversight with advanced analytics.
Siemens Healthineers has announced the launch of the CN-3000 and CN-6000 Hemostasis Systems for coagulation testing in Canada, following recent licensing from Health Canada.1 The CN-3000 and CN-6000 Systems support a broad test menu of Siemens Healthineers routine and specialty coagulation assays. These assays enable the identification of clotting abnormalities, including bleeding and thrombotic disorders, providing laboratories with a comprehensive solution for hemostasis testing.
“With the launch of the CN-3000 and CN-6000 Hemostasis Systems in Canada, we’re proud to offer laboratories advanced solutions that support high-quality, efficient, and scalable coagulation testing. These systems reflect our commitment to innovation and empowering labs to deliver confident clinical decisions with speed and precision,” said Hina Hanif, Market Development Manager for Hemostasis at Siemens Healthineers in Canada.
Additionally, the CN-3000 and CN-6000 Systems are designed for seamless integration with Siemens Healthineers Atellica Data Manager (ADM) and laboratory automation solutions, enabling a fully hands-free workflow. This includes automated sample processing—such as preparation, storage and retrieval. Connectivity with Atellica Process Manager (APM) allows centralized oversight of testing operations, providing real-time analytics to monitor key performance indicators like turnaround time and exception handling. When integrated with ADM, advanced algorithms can automate sample routing and processing decisions, supporting standardized protocols across multiple instruments and laboratory sites.
For more information about the CN Hemostasis Systems, visit :
CN-3000 and CN-6000 Systems - Siemens Healthineers Canada
Image of the Siemens Healthineers CN-3000/CN-6000 system
Siemens Healthineers CN-3000 / CN-6000 and additional sample handler added to system on the right.
Media Contact:
Samantha De Sousa
Marketing Manager, Lab Solutions and Point of Care
Siemens Healthineers, Canada
samantha.desousa@siemens-healthineers.com
About Siemens Healthineers:
Siemens Healthineers pioneers breakthroughs in healthcare. For everyone. Everywhere. Sustainably. The company is a global provider of healthcare equipment, solutions and services, with activities in more than 180 countries and direct representation in more than 70. The group comprises Siemens Healthineers AG, listed as SHL in Frankfurt, Germany, and its subsidiaries. As a leading medical technology company, Siemens Healthineers is committed to improving access to healthcare for underserved communities worldwide and is striving to overcome the most threatening diseases. The company is principally active in the areas of imaging, diagnostics, cancer care and minimally invasive therapies, augmented by digital technology and artificial intelligence. In fiscal 2024, which ended on September 30, 2024, Siemens Healthineers had approximately 73,000 employees worldwide and generated revenue of around €22.4 billion. Further information is available at www.siemens-healthineers.com.